Development of thioquinazolinones, allosteric Chk1 kinase inhibitors
Antonella Converso(United States Military Academy), George D. Hartman(Joint BioEnergy Institute), Mark E. Fraley(United States Military Academy), Edward S. Tasber(United States Military Academy), Xianzhi Mao(United States Military Academy), Steve Stirdivant(United States Military Academy), Sylvie Marie Jezequel-Sur(United States Military Academy), Rob Lobell(United States Military Academy), Joan Zugay-Murphy(United States Military Academy), Marc Abrams(Dicerna Pharmaceuticals (United States)), Keith Rickert(United States Military Academy), Laura Sepp‐Lorenzino(United States Military Academy), Bob Drakas(United States Military Academy), Kelly Hamilton(United States Military Academy), Eileen S. Walsh(United States Military Academy), R. M. Garbaccio(United States Military Academy), Carolyn A. Buser(United States Military Academy), Paul Zuck(Merck & Co., Inc., Rahway, NJ, USA (United States)), Constantine Kreatsoulas(United States Military Academy), Sanjeev Munshi(United States Military Academy), Youwei Yan(United States Military Academy), Stephen C. Beck(United States Military Academy), Timothy J. Hartingh(United States Military Academy), Weikang Tao(Shanghai Medical Information Center), Vinod Sardana(United States Military Academy)
Cited by 74
Related Papers
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
|Cancer Cell|2016|855
The importance of synthetic chemistry in the pharmaceutical industry
|Science|2019|650
CC-1065 and the Duocarmycins: Synthetic Studies
|Chemical Reviews|1997|267
Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer
|Journal of Medicinal Chemistry|2008|156
Concise Asymmetric Syntheses of Radicicol and Monocillin I
|Journal of the American Chemical Society|2001|144